5
Participants
Start Date
February 29, 2012
Primary Completion Date
June 30, 2012
Study Completion Date
January 31, 2013
Ethinyl Estradiol-Levonorgestrel combination
0.03 mg ethinyl estradiol, 0.15 mg levonorgestrel oral daily for 21 days
leuprolide acetate
single 22.5 mg subcutaneous depot suspension
Estradiol
0.05 to 0.3 mg transdermal daily for 26 days
Progesterone
50 to 100 mg vaginal suppositories twice daily for 13 days
Oregon Health & Sciences University, Department of Obstetrics and Gynecology, Women's Health Research Unit, Portland
Medical Research Foundation, Oregon
OTHER
Oregon Health and Science University
OTHER